|
Accueil > Actualité
Novartis: psoriasis drug Cosentyx shows positive results.
(CercleFinance.com) - Late-stage data supported the high efficacy and safety of psoriasis drug Cosentyx over the 5-year treatment period, Novartis said on Tuesday.
Phase III data showed Cosentyx delivered high and long-lasting skin clearance in patients with moderate-to-severe plaque psoriasis at 5 years, the Swiss group said. This data was presented for the first time at the European Academy of Dermatology and Venereology (EADV) congress in Geneva. Copyright (c) 2017 CercleFinance.com. All rights reserved. |
19/04/2024 17:30
Danoneen hausse après deux analyses positives 19/04/2024 16:35 TotalEnergiespartenariat avec OK Petroleum aux USA 19/04/2024 16:29 BAE Systemsmodernise une usine de munitions 19/04/2024 16:15 Netflixle titre trébuche après une publication contrastée 19/04/2024 16:09 Bayersigne un contrat de fourniture d'énergie renouvelables 19/04/2024 15:53 L'Oréalentouré après ses ventes trimestrielles Tous les articles sociétés |
